of Dr. E. S. Vitetta (University of Texas, Health Science Center, Dallas, TX), were cultured with test samples for 3 d as described previously (22) . BCGF activity was measured by using SAC-activated B blast cells as described before (23) . For measurements of HPGF activity, the BSF-2-dependent murine hybridoma clone, MH60.BSF2, was cultured at a cell concentration of 5 X 104/ml with test samples for 48 h. MH60 .BSF2 hybridoma was established as a clone producing mAb against human BSF-2 (Matsuda, M., et al., manuscript in preparation) . Its growth was shown to be absolutely dependent on BSF-2, as described elsewhere (Hirano, T ., M. Matsuda, M. Turner, et al., manuscript submitted for publication) . All cultures were pulsed with 1 pCi of [9H]thymidine ([sH]TdR)(15 .1 Ci/mmol; New England Nuclear, Boston MA) during the last 6 or 16 h, as indicated, and cells were harvested on glass filter paper by an automated cell harvester (Labo Mash Science Co., Tokyo, Japan) . The radioactivity was measured with a Beckman scintillation counter (Beckman Instruments, Inc., Fullerton, CA). All assays were performed in triplicate cultures.
Measurement ofBSF-2 Activity. EBV-transformed B cell lines, SKW6-CL-4 and SGB29, were cultured at 5 X 104/ml with test samples in the microplates for 4 d and IgM and IgG were measured by ELISA as described previously (7) .
PWM-induced Ig Production . MNC obtained from peripheral blood or tonsils or PWMstimulated B blast cells were cultured at a cell density of 2 X 105/well in the presence or absence of PWM together with various concentrations of test samples in the microplates for various periods as indicated. In some experiments, IgG fractions or F(ab') 2 fractions of antibodies were added to the cultures. Culture medium was replaced with fresh medium supplemented with test samples or antibodies every 4 d. The concentrations of Ig in the culture supernatant were determined by ELISA .
Results rBSF-2 Induces Ig Production in a B Cell Line and in Activated Normal B Cells . rBSF-2 induced IgM production in an EBV-transformed B cell line, SKW6-CL-4 ( Fig. 1 A) , and IgG production in another cell line, SGB29 (Fig. I B) in a dose-dependent manner, but an equivalent amount of mock preparation did not cause Ig production . The maximum Ig production in those cells was observed at a concentration of 2-20 ng/ml of rBSF-2 and 50% of the maximum response was obtained at a concentration of around 0.2 ng/ml, the specific activity of rBSF-2 being estimated as 5 X 106 U/mg. To examine the effect of rBSF-2 on Ig production of normal B cells, tonsillar MNC were cultured in the presence of varying concentrations of PWM together with rBSF-2 (1 ng/ml or 10 ng/ml) for 8 d and the amounts of Ig in the culture supernatants were determined. Representative data of three experiments with essentially similar results are shown in Fig . 2 . The addition of rBSF-2 to the culture augmented IgM, IgG, and IgA productions 3-10-fold . Equivalent amounts of mock rBSF-2 preparation did not show any enhancing effect (data not shown) . When rBSF-2 was added into the culture of peripheral blood MNC with PWM, a similar enhancement of PWM-induced Ig production was observed (Fig. 3) . As shown in Fig . 3 , kinetic studies with PWM-stimulated peripheral MNC in the presence or absence of rBSF-2 showed that rBSF-2 did not change the kinetics of the response but simply augmented the peak response ; suggesting that rBSF-2 may enhance the process normally occurring in the response.
Then it was examined whether rBSF-2 acted directly on B cells. the culture supernatants were determined . As shown in Fig. 4A , rBSF-2 induced IgG production in activated B cells in a dose-dependent manner, but had no effect on unstimulated B cells. The equivalent amount of mock preparation did not induce Ig production in PWM-stimulated B blasts (data not shown) . Contrary Duration of culture ( days ) to this, rBSF-2 did not induce [sH]TdR uptake in activated B cells, whereas rIL-2 promoted cell proliferation of the same activated B cell population (Fig. 4B) .
Effects ofAnti-BSF-2 Antibody on the PWM-induced Ig Production. The role of BSF-2 in PWM-induced Ig production was further demonstrated using the antibody specific to BSF-2 . Peripheral blood MNC were cultured with PWM together with various concentrations of anti-BSF-2 for 8 d. As shown in Fig. 5 A, the PWM-induced IgG production was inhibited up to 80% by the addition of anti-BSF-2 antibody . The inhibition was also caused by the F(ab') 2 fragment of anti-BSF-2 antibody, indicating that the inhibition was not mediated through the Fc receptor. However, anti-BSF-2 antibody had no effect on PWM-induced [3H]TdR uptake, which was measured on days 3 and 7 ( Fig. 5B) .
To examine whether the inhibition of PWM-induced Ig production by anti-BSF-2 can be overcome with rBSF-2, peripheral blood MNC were cultured with PWM and anti-BSF-2 (50 j ug/ml) in the presence of different concentrations of rBSF-2 for 7 d. The levels of IgG in the culture supernatants were determined by ELISA. As shown in Fig. 6 , the inhibitory effect of anti-BSF-2 was reversed by the addition of rBSF-2 in a dose-dependent manner.
To examine on which stage of PWM-induced Ig production BSF-2 exerts its effects, anti-BSF-2 antibody was added either at the initiation or on the 4th day of the culture. The amounts of IgG produced were measured on day 8. As shown in Fig. 7 , anti-BSF-2 antibody was effective even when added on day 4 of the culture.
Effects of rBSF-2 on a Variety of Cells Responsive to Different Kinds of Interleukins. As shown in Table 1 , rBSF-2 did not show any IL-1 or IL-2 activity . This 
Discussion
The process through which antigen-stimulated B cells mature into antibodyforming cells could be dissected into three stages ; activation, proliferation, and differentiation. Several interleukins have been demonstrated to be involved in each phase of the B cell responses (1, 2) and BSF-2 has been classified as a factor that mainly induces terminal differentiation of B cells (2, 8) . In this report, using rBSF-2, it was confirmed that BSF-2 in fact induces Ig production in PWMactivated B cells without any effect on cell proliferation . The most important result in this study is that anti-BSF-2 antibody almost completely inhibited PWM- induced Ig production, indicating that BSF-2 is one of the essential factors for PWM-induced Ig production in B cells . Anti-BSF-2 antibody was effective even when added on the fourth day of a total 8-d culture, indicating that BSF-2 acts on the late phase of the B cell response rather than the early activation phase. This is in complete agreement with the previous reports demonstrating that BSF-2 is a late acting factor for the Ig induction in SAC-activated B cells (24, 25) . In accordance with this data, Taga et al. (26) previously reported that BSF-2-receptor was expressed on the activated B cells but not on resting B cells. As reported previously with purified BSF-2 (7), rBSF-2 has no effect on the growth of anti-IgM, SAC, or PWM-stimulated B cells. Furthermore, anti-BSF-2 antibody, which suppressed PWM-induced Ig production, did not inhibit PWM-induced cell proliferation, indicating that BSF-2 is not involved in the PWM-induced proliferation of B cells. The results also excluded the possibility that the inhibitory effect of anti-BSF-2 on Ig production was due to nonspecific cytotoxic effect on activated B cells. These functional properties of BSF-2 are quite different from those of BSF-1/IL-4 (3, 4, 27), BCGF II/IL-5 (5) and neuroleukin (28) . BSF-1/IL-4 activates resting B cells (29) and induces proliferation of B cells together with anti-IgM (4, 20) . BSF-1/IL-4 can induce IgGI and IgE production in murine LPSstimulated B blast cells (3, 30) . However, the activity of BSF-1/IL-4 to induce Ig production was demonstrated to be exerted on resting B cells (31) . BSF-1/IL-4 is thus considered an activation factor . In fact, the receptors for BSF-I/IL-4 were shown to be expressed on resting B cells, in contrast to BSF-2 receptors which are expressed only on activated B cells (26, 32, 33, 34) . BCGF-II/IL-5 promotes proliferation of dextran sulfate-stimulated B cells and B lymphoma cell line, BCL-1, and induces Ig production in activated B cells (5, 35, 36) . Therefore, BCGF-II/IL-5 is a factor with growth and differentiation activities . This is in contrast to the function of BSF-2, which induces only Ig production in B cells without any growth activity . Neuroleukin was demonstrated to be one of the essential factors for PWM-induced Ig production, but its effect was restricted in an early phase of B cell response, since antineuroleukin antibody inhibited PWM-induced Ig production only when it was added at the initiation of culture (28) . Neuroleukin may directly act on B cells but the presence of T cells and monocytes is essential for neuroleukin-induced Ig secretion in B cells, indicating that several other factors such as BSF-2 are required for the process of B cell differentiation . In any case, the studies with antineuroleukin and anti-BSF-2 antibodies indicate that both factors are involved in the early and late stages of the PWM-induced B cell response, respectively . rBSF-2 enhanced PWM-induced IgM, IgG, and IgA production, suggesting that BSF-2 has no preferential effect on certain isotypes of Ig in contrast to BSF-1/IL-4, IFN -,y, and BCGF-II/IL-5 which display preferential effect on certain classes and/or subclasses of murine Ig; BSF-1/IL-4 for IgGI and IgE, IFN--Y for IgG2a (30, 37) , and BCGF-II/IL-5 for IgA (38) . However, BSF-2 might have preferential effect on a specific isotype of Ig, such as IgG2b. Al-Balaghi et al. (39) reported that synovial fluid of patients with rheumatoid arthritis (RA) contained factor(s) that preferentially induced IgG2b in LPS-stimulated murine B cells. They called the active factor BCDF and demonstrated that BCDF enhanced PWM-induced Ig production in human peripheral blood MNC without any effect on cell proliferation . They also showed that BCDF was directly effective on activated B cells. The functional properties of synovia-derived BCDF and BSF-2 seem to be similar . In fact, we recently found that synovial fluid obtained from affected joints of RA patients contains BSF-2 (Hirano, T ., M. Matsuda, M . Turner, et al., manuscript submitted for publication) . These findings suggest that BSF-2 might have preferential effect on the expression of IgG2b and this possibility remains to be determined.
The data presented in this report indicate that BSF-2 has no growth-inducing activity in normal activated B cells. However, rBSF-2 was a potent growth factor for a murine hybridoma cell line, MH60.BSF2, in complete agreement with the results obtained by Van Damme et al. (11) and Poupart et al. (14) . rBSF-2 induced 50% of the maximum [sH]TdR uptake of MH60 .BSF2 at a concentration of^" 5 pg/ml, the specific activity being calculated as 2 X 10' U/mg. The specific activity of rBSF-2 estimated on the basis of the Ig-inducing activity of EBV-transformed B lymphoblastoid cell line, SKW6-CL-4, is 5 X 106 U/mg. Van Snick et al. (40) also showed that hybridoma cells required 200 times lower BSF-2 than that required for plasmacytoma growth . The reasons why hybridoma cells are more sensitive to BSF-2 than plasmacytomas or B cell lines is not known. This could be explained by the assumption that the degree of the saturation of the receptor molecules with BSF-2 required for its functional expression might be different among a variety of cells. Alternatively, the presence of two classes of receptors with different affinity would cause the different sensitivity to BSF-2. This seems unlikely since the analysis of the BSF-2-receptor on various cells showed the presence of only a single class of receptor with high affinity (26) .
In this study, the essential role of BSF-2 in Ig induction was demonstrated in PWM-stimulated B cells using rBSF2 and anti-BSF2 antibody . It should be examined whether the results obtained with mitogen-stimulated B cells could be applied to the antigen-specific antibody response.
Summary
The role of recombinant B cell stimulatory factor 2 (BSF-2/IL-6) in the regulation of growth and differentiation of B cells was investigated . rBSF-2 at 200 pg/ml could induce 50% of the maximum Ig production in B lymphoblastoid cell lines, the specific activity being estimated as 5 X 106 U/mg. rBSF-2 augmented PWM-induced IgM, IgG, and IgA production in mononuclear cells (MNC) ; the effect was exerted by directly acting on PWM-induced B blast cells to induce Ig production. However, rBSF-2 did not induce any growth ofactivated B cells . In contrast, rBSF-2 showed a potent growth activity on a murine hybridoma clone, MI-160 .11M . The concentration required for half-maximal [3H]TdR uptake was^-5 pg/ml, which was 40 times less than that required for Ig induction in a B cell line. Anti-BSF-2 antibody inhibited PWM-induced Ig production in MNC, but not PWM-induced proliferation . The antibody was effective even when added on day 4 of an 8-d culture, indicating that BSF-2 is one of the essential late-acting factors in PWM-induced Ig production .
